Alaunos Therapeutics

TCRT69

High Growth

$2.09arrow_drop_down10.59%-$0.24

High Growth

Penny Stock

TCRT69

$2.09

arrow_drop_down10.59%-$0.24

High Growth

Penny Stock

Performance History

Key Stats
Open	$2.41
Prev. Close	$2.33
EPS	-319.97
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$3.34M
PE Ratio	-

	LOW	HIGH
Day Range	2.10	2.82
52 Week Range	1.89	33.00

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-319.97

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Alaunos Therapeutics (TCRT)

Alaunos Therapeutics, Inc. (TCRT) is a biotechnology company that specializes in the development of innovative therapies for the treatment of cancer. The company is focused on developing targeted therapies that can effectively kill cancer cells while minimizing damage to healthy cells. TCRT's mission is to revolutionize cancer treatment by providing patients with safe and effective therapies that can improve their quality of life and prolong survival.

TCRT's stock price history shows a steady upward trend over the past few years. The company has experienced significant growth in its stock value, reflecting investor confidence in the potential of its therapies. This positive trend is likely to continue as TCRT progresses in its clinical development and reaches important milestones.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Kevin S. Boyle Sr.
Headquarters: Houston
Employees: 34
Exchange: NASDAQ

Keep an eye on Alaunos Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Alaunos Therapeutics's (TCRT) price per share?

The current price per share for Alaunos Therapeutics (TCRT) is $2.09. The stock has seen a price change of -$0.25 recently, indicating a -10.59% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Alaunos Therapeutics (TCRT)?

For Alaunos Therapeutics (TCRT), the 52-week high is $33, which is 1.48K% from the current price. The 52-week low is $1.9, the current price is 10.29% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Alaunos Therapeutics (TCRT) a growth stock?

Alaunos Therapeutics (TCRT) has shown an average price growth of -6.65% over the past three years. It has received a score of 99 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Alaunos Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Alaunos Therapeutics (TCRT) stock price performance year to date (YTD)?

As of the latest data, Alaunos Therapeutics (TCRT) has a year-to-date price change of -83.61%. Over the past month, the stock has experienced a price change of -13.39%. Over the last three months, the change has been -8.33%. Over the past six months, the figure is -82.87%.

help

Is Alaunos Therapeutics (TCRT) a profitable company?

Alaunos Therapeutics (TCRT) has a net income of -$35.14M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -29.15K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$34.27M. Furthermore, the EBITDA is -$12.58M.

help

What is the market capitalization of Alaunos Therapeutics (TCRT)?

Alaunos Therapeutics (TCRT) has a market capitalization of $3.35M. The average daily trading volume is 2.32, indicating the stock's liquidity and investor engagement.